1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Czech Republic Pharmaceuticals and Healthcare Report Q4 2016

Czech Republic Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 78 pages

Includes 3 FREE quarterly updates

BMI View: A strong economic outlook will drive continued growth in both the pharmaceuticals andhealthcare markets over the coming years. As a result of the advanced nature of the market, verging on apar with Western European markets, the Czech Republic will remain the one of the most attractive marketsin Central and Eastern Europe for multinational drugmakers.

Headline Expenditure Projections

- Pharmaceuticals: CZK78.83bn (USD3.02bn) in 2015 to CZK81.15bn (USD3.28bn) in 2016; +3.0% inlocal currency terms and +8.8 % in US dollar terms. Forecasts unchanged from last quarter.

- Healthcare: CZK312.52bn (USD11.97bn) in 2015 to CZK325.75bn (USD13.19bn) in 2016; +4.2% inlocal currency terms and +10.2% in US dollar terms. Forecasts unchanged from last quarter.

Table Of Contents

Czech Republic Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Czech Republic 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Czech Republic 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Czech Republic 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Czech Republic 2014-2020) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q4 2016 31
Czech Republic - Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 40
Pricing Regime 41
Reimbursement Regime 42
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Czech Republic 2010-2015) 50
Table: Healthcare Personnel (Czech Republic 2010-2015) 50
Table: Healthcare Activity (Czech Republic 2010-2015) 51
Research and Development 54
Clinical Trials 54
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Distribution 61
Pharmaceutical Retail Sector 61
Company Profile 63
Zentiva (Sanofi) 63
Demographic Data 67
Demographic Forecast 67
Table: Population Headline Indicators (Czech Republic 1990-2025) 68
Table: Key Population Ratios (Czech Republic 1990-2025) 68
Table: Urban/Rural Population and Life Expectancy (Czech Republic 1990-2025) 69
Table: Population By Age Group (Czech Republic 1990-2025) 69
Table: Population By Age Group % (Czech Republic 1990-2025) 70
Glossary 72
Methodology 74
Pharmaceutical Expenditure Forecast Model 74
Healthcare Expenditure Forecast Model 74
Notes On Methodology 75
Risk/Reward Index Methodology 76
Index Overview 77
Table: Pharmaceutical Risk/Reward Index Indicators 77
Indicator Weightings 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.